Nymox Pharma Announces $2.1M in Equity Financing

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced a private placement equity investment of US$2.1 Million. The investment was at $2.00 per share with no warrants. The investment was made by long-term Nymox shareholders. The Company has now closed private placements totalling $3.4 Million since November 5.
Erik Danielsen, Nymox Chief Financial Officer, said:

We are very pleased with this equity infusion in these market conditions. The Company has strong long-term supporters who are very excited about our business plans, and who share our enthusiasm about near-term milestones. We are particularly pleased to have raised $3.4 Million since November 5. This will allow the Company to continue to aggressively move our projects forward without delay.

Click here to view the full press release.